-
cutting-edge technologies for genetical engineering to enhance T cell therapies of cancer. As part of the Center for Hematology and Regenerative Medicine (HERM) , the lab is part of a collaborative
-
Cruceanu. The group studies molecular mechanisms of how stress and pharmacological exposures shape early human development, aiming to understand the long-term outcomes of these exposures
-
at CMM and SciLifeLab. The overall goal for the lab is to understand fundamental mechanisms of B cell-related immune responses in cancer (and beyond) to identify new avenues for B-cell mediated therapy
-
. Despite the knowledge of diseases and their mechanisms, many promising therapeutic approaches are still clinically unavailable. There is no effective way to deliver these therapies to the right organ
-
Biology, Karolinska Institutet, Stockholm, Sweden, to study molecular mechanisms that protect against disease-related chromosomal aberrations. The Department of Cell and Molecular Biology (CMB) i is a
-
the bone and tissue regeneration. We study musculoskeletal disorders both at the clinical and molecular level in order to understand disease mechanisms. The research group is studying biomarkers of tissue
-
at elucidating mechanisms of the vascular function of small vessel disease/CADASIL and the relationship of impaired vascular function and neurodegeneration with the goal of identifying new molecular targets
-
Alzheimer’s disease. Our studies build upon in vivo and in vitro models as well as on analysis of human clinical samples, in order to elucidate the molecular and cellular mechanisms for resolving
-
Rosenquist Brandell as project leaders. The research is focused on identifying genetic causes and molecular mechanisms in rare skeletal diseases. The group works closely with the Metabolic Bone Disease group
-
experimental and translational research related primarily to Alzheimer's disease and other neurodegenerative diseases, but also more general molecular mechanisms with biomedical relevance are studied. Do you